Showing results (1401-1410 of 1,448) with videos related to

Sort By:
Pageof 145
The Lancet. Haematology|December 3, 2025
Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trialHan-Yu Cao, Hao Zhang, Yang Zhang, et al.
Gut|December 3, 2009
Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion proteinDe-Xin Zhang, Peng-Tao Zhao, Lin Xia, et al.
Iscience|November 25, 2022
Transcriptional upregulation of MAPK15 by NF-κB signaling boosts the efficacy of combination therapy with cisplatin and TNF-αDan-Dan Wu, Li-Juan Dai, Heng Wee Tan, et al.
Oncotarget|October 15, 2017
FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinomaTing-Ting Cao, Di Xiang, Bei-Lei Liu, et al.
Oncology Reports|November 29, 2013
Establishment of a green fluorescent protein tracing murine model focused on the functions of host components in necrosis repair and the niche of subcutaneously implanted gliomaZhao-Hui Lu, Ke Lv, Jin-Shi Zhang, et al.
The Annals of Thoracic Surgery|February 4, 2023
Salvage Surgery for Advanced Lung Adenocarcinoma After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor TreatmentMong-Wei Lin, Sung-Liang Yu, Yin-Chen Hsu, et al.
Frontiers in Pharmacology|August 9, 2020
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective StudyYin-Qiu Huang, Sheng-Quan Tang, Xiao-Lei Xu, et al.
Therapeutic Advances in Medical Oncology|April 28, 2023
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patientsZhen Wang, Xu-Chao Zhang, Wei-Neng Feng, et al.
Carcinogenesis|November 24, 2016
Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cellsTing-Ting Cao, Shu-Hai Lin, Li Fu, et al.
Cell Communication and Signaling : CCS|July 10, 2023
The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancerKai-Ching Hsiao, Siou-Ying Ruan, Shih-Min Chen, et al.
Pageof 145